The widespread presence of NRP1 in epithelial cells makes it a feasible entry pathway for the virus, and therefore in diabetes mellitus condition, when the glycated ACE2 receptor has lost at least part of its binding affinity for virus, NRP1 receptor could play a preferential, alternative, role of SARS-CoV-2 entry receptor. This evidence concerns the gene NRP1 and diabetes mellitus.